Dr. Harry P. Erba - CML - Chronic Myeloid Leukemia
''Dr. Harry Paul Erba, M.D. is a Hematology/Oncology specialist in Birmingham, Alabama. He is also a professor of Internal Medi and Director of the Hematologic Malignancy Program of the University of Alabama at Birmingham.
VIDEOS
Unmet Needs and Future Directions in CML
August 30, 2018, OncLiveTV
Chronic Myeloid Leukemia: Selecting Patients for TFR
August 30, 2018, OncLiveTV
CML: Improving Treatment for Patients Who Don’t Respond
August 22, 2018, OncLiveTV
Mutation Analysis in Chronic Myeloid Leukemia (CML)
January 14, 2016, OncLiveTV
More on Ponatinib and Next Steps - Harry Erba, MD
November 7, 2013, NationalCMLSociety
Dr. Harry Erba on the Analysis of Patients With CML
March 4, 2013, OncLiveTV
Dr. Harry Erba Discusses the Frontline Treatment of CML
March 28, 2012, OncLiveTV
Unmet Needs and Future Directions in CML
August 30, 2018, OncLiveTV
Chronic Myeloid Leukemia: Selecting Patients for TFR
August 30, 2018, OncLiveTV
CML: Improving Treatment for Patients Who Don’t Respond
August 22, 2018, OncLiveTV
Mutation Analysis in Chronic Myeloid Leukemia (CML)
January 14, 2016, OncLiveTV
More on Ponatinib and Next Steps - Harry Erba, MD
November 7, 2013, NationalCMLSociety
Dr. Harry Erba on the Analysis of Patients With CML
March 4, 2013, OncLiveTV
Dr. Harry Erba Discusses the Frontline Treatment of CML
March 28, 2012, OncLiveTV
